Loading...
Docoh

Leagh Erin Turner

Filed: 17 Nov 21, 4:12pm
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Turner Leagh Erin

(Last) (First) (Middle)
C/O CERIDIAN HCM HOLDING INC.
3311 EAST OLD SHAKOPEE ROAD

(Street)
MINNEAPOLIS MN 55425

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ceridian HCM Holding Inc. [ CDAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President and COO
3. Date of Earliest Transaction (Month/Day/Year)
11/15/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/15/2021 M 6,500(1) A $49.93 119,611 D
Common Stock 11/15/2021 S 5,174(1) D $119.03(2) 114,437 D
Common Stock 11/15/2021 S 1,326(1) D $119.63(3) 113,111(4) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to purchase) $38.63 (5) 09/04/2028 Common Stock 50,000 50,000 D
Option (right to purchase) $49.93 11/15/2021 M 6,500(1) (6) 03/20/2029 Common Stock 6,500 (7) 50,752 D
Option (right to purchase) $65.26 (8) 05/08/2030 Common Stock 187,321 187,321 D
Option (right to purchase) $80.95 (9) 03/08/2031 Common Stock 132,124 132,124 D
Performance Units (10) (10) 03/08/2022 Common Stock 3,237 3,237 D
Performance Units (11) (11) 03/08/2024 Common Stock 16,182 16,182 D
Explanation of Responses:
1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.56 to $119.50 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.58 to $119.72 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. Includes (i) of the 50,000 Restricted Stock Units (RSUs) granted on September 4, 2018, 29,000 shares are issuable at the election of the recipient, and 12,500 RSUs will vest and become issuable at the election of the recipient on September 4, 2022, (ii) of the 50,000 RSUs granted on September 9, 2019, 25,000 shares are issuable at the election of the recipient and 12,500 RSUs will vest and become issuable at the election of the recipient on each of September 9, 2022 and September 9, 2023, (iii) of the 1,538 RSUs granted on February 28, 2020, 512 shares are issuable at the election of the recipient, and 513 RSUs will vest and become issuable at the election of the recipient on each of February 28, 2022 and February 28, 2023, and (iv) of the 20,073 RSUs granted on May 8, 2020, 6,691 shares are issuable at the election of the recipient, and 6,691 RSUs will vest and become issuable at the election of the recipient on each of May 8, 2022 and May 8, 2023.
5. Consists of 25,000 vested and exercisable options as of September 4, 2021, and 25,000 options that vest and become exercisable on September 4, 2022.
6. Consists of 19,084 vested and exercisable options as of March 20, 2021, of which 6,500 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 19,084 options that vest and become exercisable on each of March 20, 2022 and March 20, 2023.
7. Not applicable.
8. Consists of 46,830 vested and exercisable options as of May 8, 2021, 46,830 options that vest and become exercisable on each of May 8, 2022 and May 8, 2023, and 46,831 options that vest and become exercisable on May 8, 2024.
9. These options vest and become exercisable in four annual installments beginning on March 8, 2022.
10. Each performance stock unit represents a contingent right to receive between .25 and 1.50 shares of Common Stock based upon the degree to which one or both of the Cloud Revenue and Adjusted EBITDA Margin performance metrics under the Companys 2021 Management Incentive Plan are satisfied. The performance stock units vest upon the later of (i) the date the Compensation Committee or the Board certify that one or both of the performance metrics have been met and (ii) March 8, 2022.
11. Each performance stock unit represents a contingent right to receive between .25 and 1.50 shares of Common Stock based upon the degree to which one or both of the Cloud Revenue and Adjusted EBITDA Margin performance metrics contained in the performance stock unit award agreement are satisfied. The performance stock units will only vest if the achievement of one or both of the performance metrics is certified by the Compensation Committee or the Board of Directors of the Company to have been met, and then any such certified amount will vest one-third on each anniversary of the date of grant.
Remarks:
For Leagh Turner pursuant to the Power of Attorney previously filed.
/s/ William E. McDonald, attorney-in-fact 11/17/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.